Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 2,478

The DOI matches its Crossref record.

Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018

Ferlay, J., Colombet, M., Soerjomataram, I., Dyba, T., Randi, G., Bettio, M., Gavin, A., Visser, O., Bray, F.·2018·European Journal of Cancer
DOI 10.1016/j.ejca.2018.07.005
Open this paper in CoChat — free account

Abstract

INTRODUCTION Europe contains 9% of the world population but has a 25% share of the global cancer burden. Up-to-date cancer statistics in Europe are key to cancer planning. Cancer incidence and mortality estimates for 25 major cancers are presented for the 40 countries in the four United Nations-defined areas of Europe and for Europe and the European Union (EU-28) for 2018. METHODS Estimates of national incidence and mortality rates for 2018 were based on statistical models applied to the most recently published data, with predictions obtained from recent trends, where possible. The estimated rates in 2018 were applied to the 2018 population estimates to obtain the estimated numbers of new cancer cases and deaths in Europe in 2018. RESULTS There were an estimated 3.91 million new cases of cancer (excluding non-melanoma skin cancer) and 1.93 million deaths from cancer in Europe in 2018. The most common cancer sites were cancers of the female breast (523,000 cases), followed by colorectal (500,000), lung (470,000) and prostate cancer (450,000). These four cancers represent half of the overall burden of cancer in Europe. The most common causes of death from cancer were cancers of the lung (388,000 deaths), colorectal (243,000), breast (138,000) and pancreatic cancer (128,000). In the EU-28, the estimated number of new cases of cancer was approximately 1.6 million in males and 1.4 million in females, with 790,000 men and 620,000 women dying from the disease in the same year. CONCLUSION The present estimates of the cancer burden in Europe alongside a description of the profiles of common cancers at the national and regional level provide a basis for establishing priorities for cancer control actions across Europe. The estimates presented here are based on the recorded data from 145 population-based cancer registries in Europe. Their long established role in planning and evaluating national cancer plans on the continent should not be undervalued.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ejca.2018.07.005

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 26

  1. Jensen, 1990, Cancer in the European Community and its member states, Eur J Cancer, 26, 1167, 10.1016/0277-5379(90)90278-2 · DOI · Paper page
  2. Black, 1997, Cancer incidence and mortality in the European Union: cancer registry data and estimates of national incidence for 1990, Eur J Cancer, 33, 1075, 10.1016/S0959-8049(96)00492-3 · doi:10.1016/s0959-8049(96)00492-3
  3. Bray, 2002, Estimates of cancer incidence and mortality in Europe in 1995, Eur J Cancer, 38, 99, 10.1016/S0959-8049(01)00350-1 · DOI · Paper page
  4. Boyle, 2005, Cancer incidence and mortality in Europe, 2004, Ann Oncol, 16, 481, 10.1093/annonc/mdi098 · DOI · Paper page
  5. Ferlay, 2007, Cancer incidence and mortality in Europe, 2006, Ann Oncol, 16, 481
  6. Ferlay, 2010, Estimates of cancer incidence and mortality in Europe in 2008, Eur J Cancer, 46, 765, 10.1016/j.ejca.2009.12.014 · DOI · Paper page
  7. Ferlay, 2013, Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012, Eur J Cancer, 49, 1374, 10.1016/j.ejca.2012.12.027 · DOI · Paper page
  8. World Health Organization, 2013, vol. 2
  9. Dyba, 2000, Comparison of different approaches to incidence prediction based on simple interpolation techniques, Stat Med, 19, 1741, 10.1002/1097-0258(20000715)19:13<1741::AID-SIM496>3.0.CO;2-O · doi:10.1002/1097-0258(20000715)19:13<1741::aid-sim496>3.0.co;2-o
  10. Loos, 2004, Sheep and goats: separating cervix and corpus uteri from imprecisely coded uterine cancer deaths, for studies of geographical and temporal variations in mortality, Eur J Cancer, 40, 2794, 10.1016/j.ejca.2004.09.007 · DOI
  11. De Angelis, 2014, Cancer survival in Europe 1999-2007 by country and age:results of EUROCARE-5 – a population-based study, Lancet Oncol, 15, 23, 10.1016/S1470-2045(13)70546-1 · DOI · Paper page
  12. Antoni, 2016, An assessment of GLOBOCAN methods for deriving national estimates of cancer incidence, Bull World Health Organ, 94, 174, 10.2471/BLT.15.164384 · DOI
  13. Welch, 2018, Scrutiny-dependent cancer and self-fulfilling risk factors, Ann Intern Med, 168, 143, 10.7326/M17-2792 · DOI
  14. Dal Maso, 2018, The impact of overdiagnosis on thyroid cancer epidemic in Italy, 1998–2012, Eur J Cancer, 10.1016/j.ejca.2018.01.083 · DOI
  15. Malvezzi, 2018, European cancer mortality predictions for the year 2018, with focus on colorectal cancer, Ann Oncol, 29, 1016, 10.1093/annonc/mdy033 · DOI
  16. Bray, 2010, Lung cancer mortality trends in 36 European countries: secular trends and birth cohort patterns by sex and region 1970-2007, Int J Cancer, 126, 1454, 10.1002/ijc.24855 · DOI · Paper page
  17. Soerjomataram, 2007, Excess of cancers in Europe: a study of eleven major cancers amenable to lifestyle change, Int J Cancer, 120, 1336, 10.1002/ijc.22459 · DOI
  18. Lortet-Tieulent, 2015, Convergence of decreasing male and increasing female incidence rates in major tobacco-related cancers in Europe in 1988-2010, Eur J Cancer, 51, 1144, 10.1016/j.ejca.2013.10.014 · DOI · Paper page
  19. Lauby-Secretan, 2018, The IARC perspective on colorectal cancer screening, N Engl J Med, 10.1056/NEJMsr1714643 · DOI · Paper page
  20. Carioli, 2017, Trends and predictions to 2020 in breast cancer mortality in Europe, Breast, 36, 89, 10.1016/j.breast.2017.06.003 · DOI · Paper page
  21. Héry, 2008, Quantification of changes in breast cancer incidence and mortality since 1990 in 35 countries with Caucasian-majority populations, Ann Oncol, 19, 1187, 10.1093/annonc/mdn025 · doi:10.1093/annonc/mdn025
  22. Karim-Kos, 2008, Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s, Eur J Cancer, 44, 1345, 10.1016/j.ejca.2007.12.015 · DOI · Paper page
  23. Kvåle, 2017, Prostate and breast cancer in four Nordic countries: a comparison of incidence and mortality trends across countries and age groups 1975-2013, Int J Cancer, 141, 2228, 10.1002/ijc.30924 · DOI
  24. Arnold, 2015, Recent trends in incidence of five common cancers in 26 European countries since 1988: analysis of the European Cancer Observatory, Eur J Cancer, 51, 1164, 10.1016/j.ejca.2013.09.002 · DOI · Paper page
  25. Bray, 2010, Prostate cancer incidence and mortality trends in 37 European countries: an overview, Eur J Cancer, 46, 3040, 10.1016/j.ejca.2010.09.013 · DOI · Paper page
  26. Coebergh, 2015, EUROCOURSE lessons learned from and for population-based cancer registries in Europe and their programme owners: improving performance by research programming for public health and clinical evaluation, Eur J Cancer, 51, 997, 10.1016/j.ejca.2015.02.018 · DOI

Cited by

Metadata

Authors
Ferlay, J., Colombet, M., Soerjomataram, I., Dyba, T., Randi, G., Bettio, M., Gavin, A., Visser, O., & Bray, F.
Venue
European Journal of Cancer
Publisher
Elsevier BV
Published
2018-11
Volume
103
Pages
356-387
ISSN
0959-8049 (ISSN-L)
DOI
10.1016/j.ejca.2018.07.005
OpenAlex
W2885738414
Cited by
2,478
References
0
FWCI
107.09
Type
journal article
Language
en
Open access
closed
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.